Company: SNWV
Filing Date: 2025-08-20
Form Type: 8-K
Source: 0001628280-25-040914
Chunk: 0

Company: SANUWAVE Health, Inc.
Filing Date: 2025-08-20
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As disclosed under Item 5.07 of this Current Report on Form 8-K, on August 19, 2025, the stockholders of Sanuwave Health, Inc. (the “ Company”) approved a proposal to amend the SANUWAVE Health, Inc. 2024 Equity Incentive Plan (the “ Plan”) to increase the total number of shares of common stock authorized for issuance under the Plan by 500,000 shares (the “ Amendment”). The Amendment was previously approved and adopted by the Company’s Board of Directors on June 6, 2025, subject to approval by the Company’s stockholders.

The Amendment is described in greater detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on July 10, 2025 (the “ Proxy Statement”). The description of the Amendment contained in the Proxy Statement and the foregoing description of the Amendment are qualified in their entirety by reference to the full text of the Plan, as amended, which is filed as Exhibit 10.1 hereto and incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders.